87 episodes

Beginner's Mind with Christian Soschner is a show about innovators, entrepreneurs, investors, thought leaders and the stories behind their success. Christian Soschner invites the listeners to learn with him from the best and brightest minds behind disruptive businesses, innovative investments, prolific social movements, and technologies powering game-changing innovation. In intimate conversations, the host deconstructs the stories to help turn their wisdom into practical tactics you can use to improve your life, grow your business and help your community. Join the LSG2G Community: https://lsg2g.substack.com/

Beginner's Mind Christian Soschner

    • Business
    • 5.0 • 4 Ratings

Beginner's Mind with Christian Soschner is a show about innovators, entrepreneurs, investors, thought leaders and the stories behind their success. Christian Soschner invites the listeners to learn with him from the best and brightest minds behind disruptive businesses, innovative investments, prolific social movements, and technologies powering game-changing innovation. In intimate conversations, the host deconstructs the stories to help turn their wisdom into practical tactics you can use to improve your life, grow your business and help your community. Join the LSG2G Community: https://lsg2g.substack.com/

    #87: Tuvik Beker - How to Start a Life Science Company in Israel and Raise Capital in Silicon Valley

    #87: Tuvik Beker - How to Start a Life Science Company in Israel and Raise Capital in Silicon Valley

    Fundraising in Israel and the United States – In this episode, I have a conversation with Tuvik Beker, CEO of Pangea Biomed, who has started, developed, and exited companies in the United States and Israel. Now he is developing Pangea Biomed to start the next revolution in precision oncology.

    Tuvik Beker is a seasoned entrepreneur, an experienced executive, and a strong technical leader who spent the last twenty years building, scaling, and leading companies in the healthcare, financial, and aerospace domains.

    Founded in 2018, Pangea Biomed is an Israeli biotech startup redefining cancer care. The company developed ENLIGHT – the world's most advanced multi-cancer, multi-therapy response predictor. By combining machine learning and deep RNA analysis, the company is mapping tumor molecular signatures to dynamically and adaptively personalize cancer care for a healthier world.

    ⭐In this episode, we talk about:
    The Startup Ecosystem in Israel
    Fundraising in the United States from 2000 to 2022
    3 Success Secrets to Fundraising in the US
    Precision Oncology
    The Enlight Technology

    Youtube

    🎤 Quotes:
    (11:58) “Nothing is Impossible"
    (31:05) “The Abundance of Capital is one important factor. Another one is, how the area around Stanford University welcomes immigration and foreign innovation."
    (35:33) “Many US Investors invest only in US companies”
    (40:26) “"If you want to succeed in fundraising, you need to have a wide funnel. You need to start talking to many, many venture capitalists to close a round."
    (44:21) “Be mentally ready to have 100 meetings or more to get the initial cheque.”
    (50:30) "The most important thing to bear in mind is building honest relationships with venture capitalists."
    (01:14:06) “Pangeas approach focuses on harnessing these expression abnormalities in order to attack cancer cells and spare normal healthy cells.”

    🕛 Timestamps:
    (00:00) Opening
    (05:32) The Origin of Pangea Biomed
    (07:45) The Startup Ecosystem in Israel
    (10:16) Conversation Culture in Israeli Schools
    (12:05) IDF: “Nothing is Impossible”
    (13:55) Compulsory Military Service Contributes to the Success of the Startup Eco-System
    (19:03) Founding a Start Up in Israel
    (23:15) The Big StartUp Hubs in Israel
    (25:16) StartUp Life in Tel Aviv
    (28:00) StartUp Life in Palo Alto & Stanford
    (30:52) The Role of Silicon Valley in Entrepreneurship and Venture Capital
    (33:52) Fundraising in the United States from 2000 to 2022
    (40:00) The 3 Success Secrets to Fundraising in the United States
    (56:00) Search Strategies During Fundraising in 2022 – signal.nfx.com
    (01:01:00) Recommendations when pitching US Investors
    (01:07:52) Pangea’s Solution in Precision Oncology
    (01:15:44) The Enlight Technology
    (01:20:30) How Pangea Helps to Find the Right Patient Population for Clinical Trials in Oncology
    (01:25:00) Pangea’s Collaboration Network
    (01:34:00) Enlight – Matchmaking between Patient and the right drugs
    (01:36:00) Pangea’s Business Model
    (01:40:00) Pangea’s Development Team
    (01:42:20) What is the next development step?
    (01:44:58) Advi
    Dev InterruptedWhat the smartest minds in engineering are thinking about, working on and investing in.Listen on: Apple Podcasts   Spotify
    The LSG2G Partners Experts in Life ScienceSupport the show

    • 1 hr 47 min
    #86: Tobias Silberzahn - What is the State of Health & Wellbeing in Europe

    #86: Tobias Silberzahn - What is the State of Health & Wellbeing in Europe

    In this episode, Tobias Silberzahn, McKinsey talks about biohacking 101 – habits that make a difference, digital health eco-system, and much more…

    Tobias Silberzahn is a trained biochemist and immunologist and works as a Partner in McKinsey's Berlin office, where he is a member of the Healthcare and Innovation Practice. His work focuses on healthcare innovation, health tech business-building, and digital transformation.

    Tobias leads the global Health Tech Network, a community of 1500+ health tech CEOs/Founders, where he hosts the quarterly Health Tech CEO Roundtable. As part of his work, Tobias also hosts the MedTech R&D Industry Roundtable and publishes the "eHealth Monitor Germany," an annual book about the digitization of the German health system.

    Within McKinsey, Tobias leads the Health & Wellbeing program for employees, focused on sleep, nutrition, stress management, and fitness, that was recently awarded the Brandon Hall HCM Excellence Award in Gold.

    McKinsey is a global management consulting firm committed to helping organizations accelerate sustainable and inclusive growth. McKinsey works with clients across the private, public, and social sectors to solve complex problems and create positive change for all their stakeholders. It combines bold strategies and transformative technologies to help organizations innovate more sustainably, achieve lasting gains in performance, and build workforces that will thrive for this generation and the next

    Youtube (Links to articles discussed in the podcast are in the description to the Youtube Video)

    We were talking about:
    ⭐ The European Health Care System
    ⭐ Biohacking 101
    ⭐ The Healthtech Startup Eco System
    ⭐Small Habits – Big Changes
    ⭐ The 4 Pillars of Health and Wellbeing

    🕛 Timestamps:
    (00:00) Introduction
    (05:30) The Situation of Mental Health, Health & Well-Being in Europe
    (10:10) The Role of Sleep For Health & Wellbeing
    (14:00) Mobility & Movement
    (18:43) Why Nutrition Matters
    (23:24) Healthcare and Cancer
    (29:46) Digital Tools for Managing Micro Habits
    (36:30) How Important are Digital Health Solutions for the Future Healthcare System – a Journey through State of the Art System
    (43:40) How Can Digital Tools Increase the Level of Health Literacy in Society?
    (49:30) How to Bring Health Education to all People –Solutions by McKinsey
    (58:54) How to Measure the Benefits of Happiness at Companies
    (01:02:38) The Cost of health deficits for the European Society
    (01:08:30) The Role Different Stakeholders Play to Improve the Healthcare System
    (01:16:30) Tobias Silberzahn’s Global Healthtech Network – A Community of 1,500+ Healthtech CEOs and Founders
    (01:20:30) The Future of Healthcare is Full Of Opportunities
    (01:21:35) The Role of Precision Medicine

    Do you want to support the podcast?
    Join the LSG2G Community: https://lsg2g.substack.com/subscribe
    Dev InterruptedWhat the smartest minds in engineering are thinking about, working on and investing in.Listen on: Apple Podcasts   Spotify
    The LSG2G Partners Experts in Life ScienceSupport the show

    • 1 hr 26 min
    #85: Emily Mitchell - What You Need to Know About Decentralized Clinical Trials

    #85: Emily Mitchell - What You Need to Know About Decentralized Clinical Trials

    What are decentralized clinical trials? 
    What are the benefits of decentralized clinical trials?

    Why are decentralized clinical trials the way of the future?

    Emily Mitchell,  Executive Director of ICON’s DCT team, discusses the benefits of these trials and what needs to be considered to ensure these benefits are realized. 
    Emily Mitchell has over 15 years of experience working in the CRO industry in Data Management, Project Management, and Clinical Operations. During her tenure at ICON, Emily partnered with an actigraphy vendor to run a pilot study with employees on the wear compliance and comparison of a medical grade activity tracker to a commercial grade version. 
    Before the pandemic, Emily helped set up and support the first fully decentralized trial at ICON. She has continued to present at various conferences around the best practices for decentralized studies, ensuring minimized patient and site burden while optimizing data capture. Emily is an active member of the Society of Clinical Data Management (SCDM) and has presented about decentralized trials at numerous conferences.
    ICON is the only CRO to offer all services (without the need to contract third-party services or technology) and deliver end-to-end integrated decentralized clinical trial solutions.  
    ICON supported the delivery of the first decentralized clinical trial that has had positive published results in a medical journal – Nature Medicine

    We are talking about
    ⭐ Decentralized clinical trials
    ⭐How they benefit patients
    ⭐The impact on budgeting
    ⭐Successful deployment of clinical trials an
    ⭐ Much, much more

    Youtube

    🕛 Timestamps:
    (00:00) Intro
    (03:30) Kick off with Summer Weather
    (06:30) What are Decentralized Clinical Trials (DCT)
    (07:30) Benefits of DCT
    (08:45) Real-Life Example for a DCT from ICON Plc
    (11:48) What was the Motivation to Develop the DCT Model before the Pandemic?
    (14:30) Logistics in Clinical Trials
    (16:20) Managing DCT
    (17:45) Patient Response to DCT
    (18:35) Benefits of DCT in Increasing Diversity in Patients Population
    (22:30) More Diversity in Patient Population Equals More Valuable Data
    (26:00) The Role of Social Media in Patient Recruitment
    (27:22) Data Management in Decentralized Clinical Trials
    (29:25) Improvement in Data Collection With AI/ML, Tablets, And Wearables
    (31:07) DCT and associated cost
    (34:08) Which Indications are suitable for DCT?
    (37:30) How do decentralized clinical trials impact the duration of a trial?
    (40:15) How long does the planning phase in a DCT model take?
    (43:30) ICON’s Partnership Model
    (47:13) The Demographics of Social Media as a Recruitment Tool for Clinical Trials
    (50:10) Patient Experience in DCT
    (52:57) How to Keep Patients Motivated Through a DCT
    (56:00) Data Collection by Patients
    (57:40) Long-term follow-ups in the DCT Model

    Dev InterruptedWhat the smartest minds in engineering are thinking about, working on and investing in.Listen on: Apple Podcasts   Spotify
    The LSG2G Partners Experts in Life ScienceSupport the show

    • 1 hr 4 min
    #84: Samantha Dale Strasser - Pepper Bio, MIT, And the Eco-System in Boston

    #84: Samantha Dale Strasser - Pepper Bio, MIT, And the Eco-System in Boston

    What is the best approach to starting a novel deep tech life science company?

    In this episode, I am talking with Samatha Dale Strasser, CSO, and co-founder of Pepper Bio, about her academic career at the University of Cambridge and MIT and the process of starting Pepper Bio.

    Backed by VC firm NFX, Pepper Bio uses proprietary lab methods and computational abilities to unlock a new level of sophistication in drug discovery.
    Called the "Google Maps for drug discovery" Pepper Bio helps partners find the safest, fastest route to new, effective drugs in clinical trials by analyzing transomics data.
    So far, the company has already identified applications of its technology for rare diseases in oncology, neurology, and inflammatory.

    Samantha Dale Strasser, PhD, is CSO and co-founder of Pepper Bio. Samantha co-founded Pepper Bio based on foundational work she pioneered during her PhD studies at MIT.  Her development of the first trans-omic machine learning platform revolutionizes how we discover drugs and treat disease.  This approach has already identified and validated previously unseen insights in inflammatory diseases and undruggable cancers.  She paved the way to Pepper’s first commercial partner, eager to apply this approach to central nervous system diseases. 

    We are talking about:
    ⭐The Eco-Systems in Boston
    ⭐ The Importance of Aligning Vision – Mission – Goals – Actions
    ⭐ Challenges in Drug Development
    ⭐ Fundraising strategies for the United States
    ⭐The Story Behind Pepper Bio
    ⭐ And Much, Much more

    Youtube

    🕛 Timestamps:
    (00:00) Introduction Pepper Bio and Samantha Dale Strasser
    (02:30) Start of the recording
    (03:00) Heatwaves, Paintings, and the Sky Above Boston
    (05:00) Culture in Boston/Cambridge and Cambridge, UK – MIT and the University of Cambridge
    (16:08) Samantha's Motivation to Start Pepper Bio
    (19:20) The Startup Eco-System in Boston, Massachusetts
    (21:27) The 3 Critical Key Success Factors of the Deep Tech Eco-System in Boston
    (24:40) Starting Points for Global Founders to Connect to the Eco-System in and around Boston
    (26:40) Real Life and Digital Meetings – The Best of Two Worlds
    (29:55) Fundraising in the United States – 3 Key Success Factors 
    (33:17) Relationship-building with Investors and Duration of Fundraising in 2022
    (31:08) The 3 Do's and Don'ts When Fundraising with US-Based Investors
    (44:05) Vision Statement – Pepper Bio
    (47:10) The Story Behind Pepper Bio's Foundation
    (51:12) Challenges in Drug Development to Improve Success Rates
    (55:49) Novel Solutions for Making Sense of Scientific Data
    (01:00:15) Pepper Bio's Team
    (01:03:30) The Importance of Aligning Vision – Goals – Actions
    (01:05:00) Hiring Strategy
    (01:05:30) Fundraising at Pepper Bio in 2022
    (01:09:10) What is the Best First Step Towards Entrepreneurship?
    Podcast Links:
    Podcast Community: https://lsg2g.substack.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner:
    Dev InterruptedWhat the smartest minds in engineering are thinking about, working on and investing in.Listen on: Apple Podcasts   Spotify
    The LSG2G Partners Experts in Life ScienceSupport the show

    • 1 hr 11 min
    #83: Donna LaVoie - How to Tell Your Story in 15 Slides

    #83: Donna LaVoie - How to Tell Your Story in 15 Slides

    What is the best methodology for presenting your Company to investors, industry partners, and public funding organizations?

    Here is the answer:

    In this episode, Donna LaVoie presents her famous “15-slides-methodology” in great detail.

    Donna is a proven strategic communications leader in health and science innovation. She is a trusted advisor on strategic communications issues, especially around complex problems affecting multiple stakeholders. She brings a unique combination of public and investor relations expertise, including product launch experience.

    LaVoieHealthScience was launched in 2001 after a corporate career with signature biotech companies leading strategic communications functions during tremendous growth, product and business launches, and international geographic expansion.

    As an acknowledged leader in health science communications with public and investor platforms, LaVoieHealthScience is recognized as a top 30 independent healthcare agency in the US. The agency has received more than 35 awards for its client work. It is recognized by INC.5000 Hall of Fame – Fastest Growing Private Companies, Boston Business Journal’s top Massachusetts PR firms, PharmaVOICE 100, and O’Dwyers.

    We are talking about:
    ↪️ Why 15 slides are sufficient in corporate presentations
    ↪️ Why you should have an Agenda slide
    ↪️ Why an Appendix is important
    ↪️ What is Better? Detail or Simplicity?
    ↪️ The interplay of Problem and Solution
    ↪️ Why the Team slide matters
    ↪️ Why you need to adapt the presentation to your audience
    ↪️ And much, much more

    Youtube Video

    🕛 Timestamps:
    (00:00) Intro
    (00:45) Donna LaVoie and LaVoieHealthSciences
    (02:35) Content of the Episode
    (03:00) Review of #bio2022 in San Diego
    (04:04) The 15 Slides Presentation Methodology
    (08:42) Why is the 15 Slides Methodology Relevant for Experienced Presenters?
    (12:15) Why are you here – What is your ask?
    (14:00) Why are conventions important?
    (16:05) Should Presenters consider the different cultural backgrounds when preparing for presentations?
    (16:51) The Importance of Colours
    (19:33) Storytelling, Simplicity, Novelty, and Clarity – The Ingredients of Successful Pitch Decks
    (24:00) Industry Dilemma
    (24:30) What’s Your Story? – 15 Slides Topics Overview
    (27:45) Title Slide
    (31:15) Company Snapshot
    (32:12) The Agenda  Why Creating Anticipation as a Hook Matters in Presentations
    .(33:00) Describing the Problem and the Solution – Why it Matters
    (37:15) The Market and Target Product Profile
    (40:00) Competitive Positioning
    (42:20) The Team
    (46:45) The Pipeline and Clinical Data
    (50:00) Regulatory Strategy
    (51:00) Manufacturing Strategy
    (52:35) Commercial Strategy
    (55:00) Financials
    (56:45) Summary of the Presentation
    (58:30) How Specific Should Deal terms be in a Pitch Presentation?
    (01:01:45) Ending Slide – Cultural and Diversity Considerations
    (01:03:00) How Much Time Should Executives Take to Prepare their Corporate Story for Fundraising?
    (01:05:00) How LaVoie Health Science Helps Life Science Entrepreneurs and Investors

    Podcast Links:
    Podcast Community: https:/
    Dev InterruptedWhat the smartest minds in engineering are thinking about, working on and investing in.Listen on: Apple Podcasts   Spotify
    Support the show

    • 1 hr 9 min
    #82: Irene Fialka - Inspiring Stories from 20 Years of Bringing Academic Innovation Into Business

    #82: Irene Fialka - Inspiring Stories from 20 Years of Bringing Academic Innovation Into Business

    Happy Birthday, Inits. Today 20 years ago – July 27, 2002 – Inits – Vienna’s most important high Tech Incubation Program was created.

    In this episode, I am talking with Irene Fialka, CEO of Inits. In 20 years, Inits has supported over 300 high-tech #startups with the necessary tools for a successful and sustainable market entry.

    Dr. Irene Fialka is CEO of INiTS, Vienna’s University Business Incubator (UBI), supporting entrepreneurs with R&D-based business ideas serving all academic institutions in Vienna. She has a genetics/molecular biology background and has worked with deep-tech startups since 2004.

    Under her leadership, INiTS was awarded three times by UBI Globalas, one of the TOP ranked UBIs in the world. INiTS’ startups have proven to be extremely successful in raising funds (12 x the average UBI-supported startup according to UBI Global) and finding strategic partners. She worked with the founders of, e.g., Apeptico, Blue Danube Robotics, Lexogen, Lithoz, Marinomed, mySugr, and many more. Marinomed is the first of over 300 companies that went public in 2019 (IPO on the Vienna Stock exchange).

    In collaboration with partners such as Boehringer Ingelheim, Pfizer, and Uniqa, Dr. Fialka and her team launched the HealthHubVienna (healthhubvienna.com) in 2018, an acceleration program for international health startups to drive innovation and change in the healthcare industry in Europe.

    In this episode, we are talking about:
    Success Story of Inits from 2002 to 2022Development of the Startup Eco-System in Europe3 Major Developments of Inits in the last 20 yearsInits Vision for the coming two decades Female Founders andMuch moreYoutube Video
    I wish the team of Inits all the best for their birthday celebration. Keep up your great work – it has a huge positive impact on the startup ecosystem in Europe

    🕛 Timestamps
    (00:00) Kick Off
    (03:00) Birthday Wishes
    (04:00) When Did Inits Start?
    (05:30) From 2002 to 2022 – How Did the Eco-System in Vienna Evolve?
    (07:40) Early Days of Life Science in Austria – Intercell in 1997, Alexander von Gabain, Werner Lanthaler, Max Birnstiel
    (08:25) What was Inits Starting Point in 2002?
    (09:20) Tech Transfer in Austria Early 2000 – The Days of the “Ausseninsitut”
    (12:32) Business Models of Academic StartUps and Their Challenges – from 2002 to 2022
    (15:20) Impressive KPIs of Inits
    (19:00) Companies are About Making Revenues
    (21:16) Inits For Academic Startups in 2022
    (26:35) Public Funding in Austria
    (27:32) How the Campus in St. Marx Developed since 2006 – Vienna Bio Center, Start-Up Labs, Inits. 
    (29:45) INits Support in 2004
    (31:00) Coaching, Mentoring, and Advising for Startups
    (32:30) The 3 Major Developments at INITS Since 2002
    (38:20) INiTs StartUps In Africa
    (43:20) Challenges and Opportunities in the Global StartUp Eco-System
    (45:05) StartUp Success Stories from the Inits Universe – MySugr, Shpock, Zoho, Marinomed, Origimm, Lithos, Ecop
    (52:05) Consistency between Strategy and Action – Aligning Interests
    (55:05) 3 Avoidable Mistakes in Startups  

    Dev InterruptedWhat the smartest minds in engineering are thinking about, working on and investing in.Listen on: Apple Podcasts   Spotify
    The LSG2G Partners Experts in Life ScienceSupport the show

    • 1 hr 23 min

Customer Reviews

5.0 out of 5
4 Ratings

4 Ratings

Smurfteer ,

Fantastic

Christian brings an extremely intelligent mind and deep curiosity to the podcast. When he interviews his guests he digs deep to not only glean the business gems they have to offer but who, as a person, they are as well. It brings a level of humanity to an excellent podcast. Highly recommend.

mherschberg ,

A great resources for life science entrepreneurship

If you want to be an entrepreneur in life sciences this podcast is a great way to get started. Christian knows the field well and brings on experts to help you learn.

Trevor Oldham ,

Awesome!

One of my new fav podcasts!